Express Scripts Ethical Violations: Billing, Privacy & Sales
This paper analyzes the ethical failures of Express Scripts, a pharmaceutical benefits management company founded in 1986. Despite steady earnings growth, the company became embroiled in several serious ethical controversies, including encouraging physicians to switch patients to generic drugs while billing insurers at brand-name rates, targeting senior citizens with misleading mail-order drug programs, engaging in unauthorized billing practices, and failing to protect millions of customers' personal health records from hackers. The paper argues that a corporate culture focused exclusively on profit — reinforced by lavish executive compensation — allowed these violations to persist, resulting in multi-state legal settlements and widespread consumer harm.
- Introduction: Framing ethical failures through executive pay context
- Express Scripts Company Overview: Company history, model, and earnings growth
- Drug Switching and Billing Fraud: Multi-state lawsuit over generic drug billing scheme
- Predatory Sales Tactics Targeting Senior Citizens: Mail-order program complaints targeting elderly customers
- Unauthorized Billing and Customer Complaints: Unauthorized charges and billing misconduct examples
- Data Security Failure and Extortion: Hackers breach records; extortion attempt goes undetected
- Conclusion: Pattern of profit-driven misconduct likely to continue
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Uses concrete, documented incidents — the $9.5 million multi-state settlement, the Better Business Bureau advisory, and the extortion/data breach — as evidence rather than relying on general claims.
- Incorporates a direct customer complaint quotation that gives a human dimension to abstract billing misconduct, making the ethical argument more persuasive.
- Connects executive compensation data to corporate behavior, framing lavish pay packages as both a symptom and driver of the ethical culture being criticized.
Key academic technique demonstrated
The paper uses a pattern-of-conduct argument: rather than treating each ethical lapse as an isolated event, it builds a cumulative case that the violations share a common root cause — profit maximization at the expense of customers. This technique is effective in ethics essays because it shifts the burden from proving intent in any single incident to demonstrating a systemic failure of corporate governance.
Structure breakdown
The paper opens with a framing introduction linking executive compensation to ethical culture, then provides a brief company overview for context. Four distinct ethical issues are each given their own analytical section. A short synthesis paragraph before the conclusion ties the incidents together, and the conclusion restates the central argument and offers a predictive warning about future misconduct. This issue-by-issue structure keeps evidence organized and easy to follow.
Introduction
Over the last several years, the issue of ethical business practices has been consistently brought to the forefront. Part of the reason for this is the various loopholes that many corporate executives have exploited to maximize their profits, utilizing a number of questionable tactics to achieve their objectives. A telling example can be found in the case of Express Scripts, a company that wrestled with a number of serious ethical controversies while simultaneously awarding its CEO a compensation increase — from $340 thousand in 2008 to $10.6 million in 2009 — with a total compensation package valued at $34 million (Brin). This is significant because it underscores how, during a period of documented unethical business practices, the company was rewarding its officers with lavish pay packages. Such a standard within the organization effectively incentivized unscrupulous behavior as a means of improving the bottom line.
Examining the business model of Express Scripts and the various ethical issues the company faced provides the clearest insight into how these practices were used to drive profits at the expense of customers and the public interest.
Express Scripts Company Overview
Founded in 1986, Express Scripts is a pharmaceutical benefits management company whose primary objective is to provide consumers with affordable solutions for purchasing prescription drugs. Based in Saint Louis, Missouri, the company achieves this goal through a database service that works in conjunction with pharmacies, healthcare providers, and HMOs. The service provides detailed information on prescription drugs, available generics, cost-saving opportunities, and a wide variety of drug options. This information is available to members of health organizations that maintain an alliance with Express Scripts ("About Us"). The platform is designed to give health organizations an effective way to manage their operations while also supplying consumers with information about prescription and generic drug options.
When examining the company's overall earnings trend, it is clear that revenues rose dramatically between 2004 and 2009 — growing from $0.98 per share in 2004 to $3.58 in 2009 — with analysts at the time estimating earnings of $4.95 for the following year ("Earnings Estimates").
Create your account
Always verify citation format against your institution’s current style guide requirements.